Video Experimental Relacionado

Updated: Apr 25, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

CD82 restringe la angiogénesis patológica al alterar el agrupamiento de las balsas de lípidos y el tráfico de CD44 en

Quan Wei¹, Feng Zhang¹, Mekel M Richardson¹

¹From the West China Hospital, Sichuan University, Chengdu, China (Q.W.); University of Oklahoma Health Science Center, Oklahoma City (Q.W., F.Z., M.M.R., W.R., Y.L., C.F., Y.D., C.H., L.D., Y.H., J.M., X.A.Z.); University of Vermont, Burlington (N.H.R., M.T.); University of Tennessee, Memphis (W.Z., Y.C., Y.S.); Tongji Hospital, Wuhan, China (Y.D., X.H.); Indiana University, Indianapolis (M.E.B.); Oklahoma Medical Research Foundation, Oklahoma City (S.P., J.D.W.); and German Cancer Research Center, Heidelberg, Germany (S.T., G.J.H.).

|August 24, 2014

Resumen

La tetraspanina CD82 restringe la angiogénesis patológica al inhibir el movimiento de las células endoteliales. Su ausencia mejora la migración celular y la invasión, ofreciendo un potencial objetivo terapéutico para enfermedades relacionadas con la angiogénesis.

Área de la Ciencia:

Biología Vascular Biología Vascular
La señalización celular.
La medicina molecular es una medicina molecular.

Sus antecedentes:

La angiogénesis es vital en enfermedades como el cáncer y la inflamación.
La regulación de la angiogénesis por parte de las células endoteliales (CE) no se comprende completamente.
Se desconoce el papel vascular de la tetraspanina CD82 en las EC.

Objetivo del estudio:

Investigar la función de CD82 en la angiogénesis.
Determinar cómo CD82 influye en el comportamiento de las células endoteliales.
Explorar el papel de CD82 en la angiogénesis patológica.

Principales métodos:

Examinó la angiogénesis en ratones Cd82-null utilizando ensayos in vivo y ex vivo.
Se analizaron las funciones celulares, las interacciones moleculares y la señalización en Cd82-null ECs.
Se evaluaron los cambios en las moléculas de adhesión celular, las balsas lipídicas y la endocitosis.

Principales resultados:

La ablación de Cd82 aumentó significativamente las respuestas angiogénicas.
Cd82-null ECs mostraron una mayor migración e invasión.
Se observaron un aumento de la regulación de CD44 e integrinas, un aumento de la agrupación de las balsas lipídicas y una endocitosis alterada.

Conclusiones:

CD82 inhibe la angiogénesis patológica al restringir el movimiento de EC.
El agrupamiento de balsas de lípidos y el tráfico de moléculas de adhesión celular regulan el potencial angiogénico.
La modulación de la señalización CD82-ganglioside-CD44 puede atenuar la angiogénesis patológica.

Palabras clave:

Movimiento celular movimiento celular.La endocitosis es la endocitosis.micro dominios de membrana de las membranas.neovascularización, patología patológica.

Más Videos Relacionados

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix

Published on: August 14, 2016

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

Videos de Conceptos Relacionados

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...

Notch Signaling Pathway

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...